Bicocca Open Archive

Logo unimib boa
STRAZZABOSCO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.748
AS - Asia 11.531
EU - Europa 10.256
SA - Sud America 1.642
AF - Africa 164
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 23
Totale 49.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.207
SG - Singapore 4.162
CN - Cina 3.104
HK - Hong Kong 2.055
RU - Federazione Russa 1.904
SE - Svezia 1.634
IT - Italia 1.374
BR - Brasile 1.331
DE - Germania 1.298
IE - Irlanda 1.242
UA - Ucraina 1.137
VN - Vietnam 1.101
GB - Regno Unito 596
CA - Canada 433
FI - Finlandia 305
KR - Corea 241
IN - India 217
FR - Francia 177
AR - Argentina 147
TR - Turchia 126
AT - Austria 117
DK - Danimarca 104
NL - Olanda 99
ZA - Sudafrica 85
BD - Bangladesh 83
JP - Giappone 78
MX - Messico 78
IQ - Iraq 69
ID - Indonesia 67
PL - Polonia 47
BE - Belgio 46
EC - Ecuador 44
ES - Italia 42
CO - Colombia 31
EU - Europa 27
PK - Pakistan 27
BG - Bulgaria 26
SA - Arabia Saudita 26
MA - Marocco 24
VE - Venezuela 24
CZ - Repubblica Ceca 23
IR - Iran 23
TW - Taiwan 22
UZ - Uzbekistan 21
CL - Cile 19
PY - Paraguay 16
AU - Australia 14
MY - Malesia 13
RO - Romania 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
KE - Kenya 12
LT - Lituania 12
UY - Uruguay 12
JO - Giordania 11
PH - Filippine 10
EG - Egitto 9
NZ - Nuova Zelanda 9
PE - Perù 9
DZ - Algeria 8
NO - Norvegia 8
OM - Oman 8
BO - Bolivia 7
JM - Giamaica 7
TN - Tunisia 7
BY - Bielorussia 6
IL - Israele 6
KZ - Kazakistan 6
MD - Moldavia 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
KW - Kuwait 5
NP - Nepal 5
PT - Portogallo 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CR - Costa Rica 4
ET - Etiopia 4
MM - Myanmar 4
BH - Bahrain 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
RS - Serbia 3
TH - Thailandia 3
AL - Albania 2
AM - Armenia 2
GA - Gabon 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
MU - Mauritius 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
Totale 49.374
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.259
Woodbridge 2.789
Singapore 2.332
Fairfield 2.114
Hong Kong 2.037
Houston 1.906
Ashburn 1.889
Chandler 1.335
Jacksonville 1.215
Dublin 1.206
Wilmington 1.000
Seattle 880
Frankfurt am Main 817
Cambridge 769
New York 626
Dearborn 556
Princeton 534
Beijing 445
Hefei 433
Santa Clara 425
Milan 405
Ho Chi Minh City 325
Dallas 301
Nanjing 292
Los Angeles 271
Lawrence 228
Hanoi 223
Seoul 219
The Dalles 208
Altamura 204
Lachine 197
Shanghai 193
Buffalo 135
Chicago 135
Moscow 130
San Diego 129
Council Bluffs 126
Boardman 115
São Paulo 114
Guangzhou 110
Shenyang 88
Vienna 88
Toronto 77
Andover 76
Nanchang 73
Helsinki 71
Changsha 68
Ottawa 64
Hebei 63
Rome 63
Falls Church 57
London 57
Hangzhou 55
Tianjin 53
Jiaxing 50
San Jose 50
Columbus 49
Norwalk 49
Rio de Janeiro 49
Tokyo 49
Dong Ket 47
Mountain View 45
Fremont 44
Munich 44
Philadelphia 44
Brooklyn 42
Jakarta 42
Jinan 42
Salt Lake City 40
Nuremberg 38
Zhengzhou 38
Da Nang 37
Boston 36
Brussels 36
Huizen 36
Johannesburg 36
Kunming 34
Haiphong 33
Warsaw 33
Montreal 32
Elk Grove Village 31
Orem 31
Pune 31
Belo Horizonte 29
Brasília 29
Lissone 29
Redmond 29
Phoenix 27
Tampa 27
Mexico City 26
Ningbo 26
San Mateo 26
Baghdad 25
Denver 23
Dhaka 23
Porto Alegre 23
San Francisco 22
Auburn Hills 21
Chennai 21
Guayaquil 21
Totale 33.175
Salva come PNG Salva come JPEG
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 576
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 468
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 436
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTATIZATION IN CHOLANGIOCARCINOMA 408
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 398
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 336
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 328
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 327
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 288
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 283
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 282
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 277
Health related quality of life in chronic liver diseases 276
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 275
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 270
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 264
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 261
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 258
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 255
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 251
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 250
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 250
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 250
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 250
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 248
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 248
The impact of liver disease on the health-related quality of life 246
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 244
Cholangiocyte biology as relevant to cystic liver diseases 243
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice 243
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 243
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 243
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 243
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 241
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 241
Effect of Silibinin on biliary lipid composition. Experimental and clinical study 239
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 235
Health Related Quality of Life in the Major Liver Conditions 235
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 234
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 233
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 230
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 228
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 227
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 227
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 226
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 223
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 221
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 220
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 218
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 218
Liver-allocation policies for patients affected by HCC in Europe 218
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 217
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 216
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 215
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 215
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4NF-κB-mediated inflammatory response in mice 214
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 213
"The city of Hepar": Rituals, gastronomy, and politics at the origins of the modern names for the liver 213
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 213
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 213
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 213
The challenges of primary biliary cholangitis: What is new and what needs to be done 213
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTASIZATION IN CHOLANGIOCARCINOMA 212
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 212
Foxa1 and Foxa2 regulate bile duct development in mice 211
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 211
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 211
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 209
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 209
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 208
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. 207
The cholangiopathies: disorders of biliary epithelia 207
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 206
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 206
Difference in health related quality of life of chronic liver diseases and general population 206
Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL 205
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 205
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 205
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 205
Animal models of cholestasis: An update on inflammatory cholangiopathies 203
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 202
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. 202
Vascular biology of the biliary epithelium 202
Cholangiocyte pathobiology 202
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice 201
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 201
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations 200
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 200
Intracellular pH regulation in isolated rat bile duct epithelial cells 198
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 198
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers 197
Notch signaling and new therapeutic options in liver disease 197
Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line 195
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 194
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 194
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 194
Altered store operated calcium entry increases cAMP production and ERK1/2 phosphorylation in Polycystin-2 defective cholangiocytes 194
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 194
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 194
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 194
Totale 23.878
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.526
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.351 0 0 0 0 0 269 378 313 380 434 274 303
2021/20222.877 130 293 499 219 101 210 133 197 143 199 244 509
2022/20235.338 594 1.602 470 404 435 810 72 278 369 31 178 95
2023/20243.783 151 142 112 179 505 1.038 764 139 333 33 24 363
2024/20258.323 551 1.073 423 324 775 275 522 405 757 1.178 652 1.388
2025/20269.719 2.210 1.393 1.359 1.726 2.090 941 0 0 0 0 0 0
Totale 50.400